share_log

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities

SEC announcement ·  Feb 17 06:22
Summary by Futu AI
CR Group L.P., a significant stakeholder in T2 Biosystems, Inc. [TTOO], reported acquiring additional shares of the company's common stock on February 14, 2024. The transactions were made indirectly through two entities. CRG Partners III (Cayman) Lev AIV I L.P. acquired 335,947 shares, while CRG Partners III Parallel Fund B LP added 488,273 shares to their holdings. Following these transactions, the total number of shares held by CR Group L.P. in T2 Biosystems amounts to 824,220. The acquisitions were made indirectly, signifying an increase in CR Group L.P.'s investment in the medical diagnostic company.
CR Group L.P., a significant stakeholder in T2 Biosystems, Inc. [TTOO], reported acquiring additional shares of the company's common stock on February 14, 2024. The transactions were made indirectly through two entities. CRG Partners III (Cayman) Lev AIV I L.P. acquired 335,947 shares, while CRG Partners III Parallel Fund B LP added 488,273 shares to their holdings. Following these transactions, the total number of shares held by CR Group L.P. in T2 Biosystems amounts to 824,220. The acquisitions were made indirectly, signifying an increase in CR Group L.P.'s investment in the medical diagnostic company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.